Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
Attachment
Visualization of efficacy endpoints in oncology clinical trials
RESONATE-2 - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
KarMMa Trial ORR | ABECMA® (idecabtagene vicleucel)
Efficacy I PLUVICTO
ORR (Objective Response Rate) and related statistics – Part 1
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Efficacy - Overall Response Rate | Aliqopa US HCP
ORR - "Objective Response Rate" by AcronymsAndSlang.com
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
ODOMZO® (sonidegib) | Efficacy Data
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Efficacy - ORR | VITRAKVI® (larotrectinib)
Efficacy endpoints in Oncology
Confirmed ORR and Median DOR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Efficacy | LIBRETTO-001 Trial | Retevmo® (selpercatinib) | HCP
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Objective response rate (ORR) and progression-free survival... | Download Scientific Diagram
Overall Response Rate | CALQUENCE® (acalabrutinib) 100 mg tablets | For HCPs
ORR (Objective Response Rate) and related statistics – Part 1
A) Overall response rate by cohorts. ORR indicates a response of PR or... | Download Scientific Diagram
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
ORR (Objective Response Rate) and related statistics – Part 1
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Abbreviations: CR, complete response; ORR, objective response rate; PR,... | Download Scientific Diagram
iLLUMINATE - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
